LAVA Therapeutics (LVTX) Earnings Date, Estimates & Call Transcripts $1.56 -0.01 (-0.32%) Closing price 03:59 PM EasternExtended Trading$1.56 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LAVA Therapeutics Earnings Summary LAVA Therapeutics posted Q2 2025 earnings on August 13, 2025, reporting an EPS of -$0.32, which missed analysts' consensus estimates of -$0.28 by $0.04. With a trailing EPS of -$1.05, LAVA Therapeutics' earnings are expected to decrease next year, from ($1.13) to ($1.30) per share. Latest Q2 Earnings DateAug. 13EstimatedConsensus EPS (Aug. 13) -$0.28 Actual EPS (Aug. 13) -$0.32 Missed By -$0.04 Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)Powered by Get LAVA Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LAVA Therapeutics and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataLVTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LVTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. LAVA Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.40-$0.23-$0.32Q2 20252-$0.38-$0.23-$0.31Q3 20252-$0.35-$0.22-$0.29Q4 20252-$0.33-$0.23-$0.28 FY 2025 8 -$1.46 -$0.91 -$1.19 Q1 20261-$0.21-$0.21-$0.21Q2 20261-$0.20-$0.20-$0.20Q3 20261-$0.19-$0.19-$0.19Q4 20261-$0.06-$0.06-$0.06 LAVA Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025-$0.28-$0.32 -$0.04-$0.32--5/14/2025Q1 2025-$0.37-$0.13+$0.24-$0.13--3/28/2025Q4 2024-$0.32-$0.14+$0.18-$0.14$2.40M$2.50M12/10/2024Q3 2024-$0.35-$0.46 -$0.11-$0.46--8/20/2024Q2 2024-$0.36-$0.31+$0.05-$0.31--5/21/2024Q1 2024-$0.25-$0.02+$0.23-$0.02-$6.99M3/20/2024Q4 2023$0.16-$0.24 -$0.40-$0.24$25.00M$0.35M11/16/2023Q3 2023-$0.49-$0.34+$0.15-$0.34-$0.05M LAVA Therapeutics Earnings - Frequently Asked Questions When did LAVA Therapeutics announce their last quarterly earnings? LAVA Therapeutics (NASDAQ:LVTX) last announced its quarterly earning data on Wednesday, August 13, 2025. Learn more on LVTX's earnings history. Did LAVA Therapeutics beat their earnings estimates last quarter? In the previous quarter, LAVA Therapeutics (NASDAQ:LVTX) missed the analysts' consensus estimate of ($0.28) by $0.04 with a reported earnings per share (EPS) of ($0.32). Learn more on analysts' earnings estimate vs. LVTX's actual earnings. How much revenue does LAVA Therapeutics generate each year? LAVA Therapeutics (NASDAQ:LVTX) has a recorded annual revenue of $11.98 million. How much profit does LAVA Therapeutics generate each year? LAVA Therapeutics (NASDAQ:LVTX) has a recorded net income of -$25.11 million. LVTX has generated -$1.05 earnings per share over the last four quarters. What is LAVA Therapeutics' EPS forecast for next year? LAVA Therapeutics' earnings are expected to decrease from ($1.13) per share to ($1.30) per share in the next year. More Earnings Resources from MarketBeat Related Companies Scilex Earnings Date Cellectis Earnings Date Coherus Oncology Earnings Date Alpha Cognition Earnings Date Eledon Pharmaceuticals Earnings Date Molecular Partners Earnings Date Theratechnologies Earnings Date Cabaletta Bio Earnings Date Avalo Therapeutics Earnings Date Greenwich LifeSciences Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Celsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 EarningsWhy Broadcom's Q3 Earnings Were a Huge Win for AVGO BullsAffirm Crushes Earnings Expectations, Turns Bears into BelieversAmbarella's Earnings Prove Its Edge AI Strategy Is a WinnerWhat to Watch for From D-Wave Now That Earnings Are DoneDICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy? This page (NASDAQ:LVTX) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersThis stock just surpassed PalantirThe media hasn't caught up to the story yet, but when they do, this stock could leave Nvidia in the dust. I...InvestorPlace | SponsoredOne tiny company just cracked Google’s $19B problemTucked away outside San Antonio sits a facility most Americans don’t know exists. It’s not mining gold or o...True Market Insiders | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredTrump’s reported death a hoaxHow Trump’s latest policies could trigger a full-scale debt collapse… And the specific investments that cou...Porter & Company | SponsoredWorld War 3? Everything Just Changed — and One Tiny Company Is at the Center of It.Trump immediately activated a $5.3 TRILLION AI missile shield — code-named Golden Dome — to stop drone swarms ...Angel Publishing | SponsoredLitecoin’s Creator Backs the World’s First TreasuryBitcoin's corporate adoption story has been written. Litecoin's is just beginning.The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LAVA Therapeutics N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share LAVA Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LVTX Stock Alerts